Jun 24 |
Axogen, Inc Announces Full Launch of Avive+ Soft Tissue Matrix™
|
Jun 12 |
Strength Seen in AxoGen (AXGN): Can Its 5.4% Jump Turn into More Strength?
|
May 28 |
Axogen Processing Center (APC) Celebrates its Opening with Ohio Leaders in Vandalia
|
May 17 |
AxoGen (AXGN) Initiates BLA Submission for Avance Nerve Graft
|
May 16 |
Axogen Inc. Initiates Rolling Submission of Biologics License Application to U.S. Food and Drug Administration (FDA) for Avance Nerve Graft®
|
May 14 |
Axogen, Inc to Participate at Leerink Partners Healthcare Crossroads Conference
|
May 6 |
AxoGen, Inc. (NASDAQ:AXGN) Q1 2024 Earnings Call Transcript
|
May 5 |
AxoGen, Inc. (AXGN) Q1 2024 Earnings Call Transcript
|
May 3 |
AxoGen First Quarter 2024 Earnings: Misses Expectations
|
May 3 |
Axogen Inc (AXGN) Q1 2024 Earnings Call Transcript Highlights: Navigating Growth Amidst Challenges
|